BioSpace News Archive

Business

Aeterna Zentaris Reports Second Quarter 2023 Financial Results

Aeterna Zentaris Inc., a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, reported its financial and operating results for the quarter ended June 30, 2023.

August 9, 2023
·
8 min read
Genetown

Ocular Therapeutix™ to Present at the H.C. Wainwright 3rd Annual Ophthalmology Virtual Conference

Ocular Therapeutix, Inc. today announced that Antony Mattessich, President and Chief Executive Officer of Ocular Therapeutix, will participate in a panel at the H.C. Wainwright 3rd Annual Ophthalmology Virtual Conference on Wednesday, August 16, 2023 at 11:00 AM EDT.

August 9, 2023
·
1 min read
Genetown

SaponiQx Announces Breakthrough in Scaling Up of STIMULON™ Cultured Plant Cell Adjuvant

SaponiQx, the adjuvant subsidiary of Agenus Inc. (NASDAQ: AGEN), specializing in saponin-based adjuvant discovery and manufacturing, has achieved a milestone in scaling the production of its STIMULON cultured plant cell (cpc) QS-21 adjuvant, designed to amplify the efficiency and endurance of vaccines.

August 9, 2023
·
3 min read
Pharm Country

Crystal IS and Asahi Kasei Announce First 4-inch Aluminum Nitride Substrate

Crystal IS, an Asahi Kasei company, announced the successful production of a 4-inch diameter single-crystal aluminum nitride substrate.

August 9, 2023
·
3 min read
Drug Development

Pharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in Japan

Pharming Group N.V. announces that the first patient has been enrolled in its Phase III clinical trial in Japan evaluating leniolisib for the treatment of activated phosphoinositide 3-kinase delta syndrome in adult and pediatric patients 12 years of age and older.

August 9, 2023
·
8 min read
Business

Novozymes delivers results within expectations in the first half of 2023 and narrows the full year outlook

Novozymes delivers 3% organic sales growth, an EBIT-margin of 25% before special items, and ROIC including goodwill of 17% before special items in the first half of the 2023 financial year.

August 9, 2023
·
5 min read
Business

Photocure ASA: Results for the second quarter and first half of 2023

Photocure ASA reported Hexvix®/Cysview® revenues of NOK 115.9 million in the second quarter of 2023, and an EBITDA of NOK 23.4 million.

August 9, 2023
·
6 min read
BioMidwest

Anteris Technologies Commences American Depository Receipt Program

Anteris Technologies Ltd, reported that it has established a sponsored Level 1 American Depository Receipt program in the United States.

August 9, 2023
·
3 min read
Business

BiomX Reports Second Quarter 2023 Financial Results and Provides Business Update

BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today reported financial results and provided a business update for the second quarter ended June 30, 2023.

August 9, 2023
·
11 min read
Business

Antion Welcomes John Tchelingerian as Chairman of the BoardNew Board Chairman appointed to position Antion for its next phase of growth and development

Antion Biosciences SA proudly announces the appointment of John Tchelingerian, PhD, a veteran of the biotech industry, as the new Chairman of its Board of Directors.

August 9, 2023
·
2 min read